Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06106672
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2023-10-24
Brief Title:
Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Sponsor:
COUR Pharmaceutical Development Company Inc
Organization:
COUR Pharmaceutical Development Company Inc
Organization Data
Organization:
COUR Pharmaceutical Development Company Inc
Class:
INDUSTRY
Study ID:
CNP-106-5001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
COUR Pharmaceutical Development Company Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None